Skip to content
healthcare.dev

Desvenlafaxine

NDC 0591-3660, Desvenlafaxine, tablet, extended release, from Actavis Pharma, Inc..

Product NDC
0591-3660
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204065
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3660 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DESVENLAFAXINE SUCCINATE100 mg/1

Pharmacologic classes

Cytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]

Package NDCNDC-11Package
0591-3660-300059136603030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-3660-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/617476f9-62d7-40ef-a1b1-c349d4ad706f
  • NADAC price for package 00591366030

    GET /v1/drugs/nadac/00591366030

Use it

Look up 0591-3660 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3660 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-3660. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.